Sign In
Get Clay Free →

Suggestions

    Todd Ranheim

    Vaccine Technical Lead at Resilience

    Todd Ranheim is a seasoned scientific professional with over 20 years of experience in building, developing, and leading cross-functional teams. He currently spearheads the vaccine CMC group at RESILIENCE, focusing on innovative solutions to technical challenges.

    With a robust educational background that includes Executive Education from MIT Sloan School of Management, a PhD in Cell and Molecular Biology from Saint Louis University School of Medicine, and a Bachelor of Arts in Biology from Rice University, Todd possesses a strong foundation for his work in the biopharmaceutical industry.

    Throughout his career, Todd has held pivotal roles in various organizations, including serving as the Vaccine Technical Lead at Resilience, Scientific Advisory Board member at Denteric, Senior Director of Vaccine Analytical Development at Takeda Pharmaceuticals, and Head of Bioassay & Immunoassay Development as well as Analytical Development at Novartis Vaccines and Diagnostics.

    His expertise extends to developing outsourcing strategies, managing external partnerships, and implementing innovative solutions for technical issues. Todd has a proven track record of overseeing budgets effectively, including direct, indirect, and capital budgets.

    From his contributions as a Technical Advisor at Ben Franklin Technology Partners of Southeastern Pennsylvania to his roles at Merck & Co., Inc., The Scripps Research Institute, and St. Louis University, Todd Ranheim has demonstrated a deep commitment to advancing the field of biopharmaceuticals through his leadership and scientific acumen.

    Todd Ranheim
    Add to my network

    Location

    Cambridge, Massachusetts, United States